Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Silicone Rubber Pieces Spur Recall of Teva Product

July 31, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

Teva Parenteral Medicines initiates voluntary nationwide recall of select lots of Adrucil due to particulate matter.

Biosimilars Council Opposes IP Provisions in Trans-Pacific Partnership

July 30, 2015

The Generic Pharmaceutical Association and the Biosimilars Council wrote an open letter to President Barack Obama protesting the patent protections outlined in the Trans-Pacific Partnership.

FDA Approves Praluent, the First PCSK9 Inhibitor in the US

July 27, 2015

FDA approved the drug for a more narrow indication in the US than did EMA for Repatha, Praluent’s fiercest competitor.

GSK’s Malaria Vaccine Gets Positive Opinion from EMA

July 24, 2015

EMA gives GSK’s malaria candidate vaccine a positive opinion for the prevention of malaria in young children in sub-Saharan Africa.

Capsugel Expands Capabilities at its Edinburgh Facility

July 23, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

Investment at Capsugel’s Edinburgh, Scotland facility will expand the company’s liquid- and semi-solid-fill capsule manufacturing capacity.

Improved characterization of twin-screw extrusion enables increasing use in pharmaceutical manufacturing.

3M Launches Production-Scale Sizes of its Upstream Purifiers

July 14, 2015

The new sizes follow the 2014 launch of the company’s fully disposable purifier.

EMA Clarifies HPV Vaccine Safety Profile

July 13, 2015

The European Medicines Agency reviews the safety of human papillomavirus vaccines.